1.5T Intraoperative MR Imaging in Craniopharyngiomas
Study Details
Study Description
Brief Summary
Purpose of this study is to investigate whether intraoperative imaging using a 1.5T MRI in craniopharyngioma surgery is useful in order to increase the rate of complete tumor removal.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intraoperative imaging
|
Other: Intraoperative imaging using 1.5T MRI
Intraoperative imaging and determination of degree of resection / complete tumor removal
|
Outcome Measures
Primary Outcome Measures
- Rate of additional tumor removal [up to 3-4 months following surgery]
Number of patients in whom non suspected tumor remants were indicated by intraoperative MRI and remnants could be removed completely thereafter. Results have to be confirmed in 1st follow up imaging.
- Rate of achievement of intended extent of removal [up to three months following surgery]
It is examined whether the extent of tumor removal defined prior to surgery was achieved
- Diagnostic reliability [within 3 -4 months following surgery]
false positive or negative interpretation of intraoperative imaging determined after follow-up imaging 3 - 4 months following surgery
Secondary Outcome Measures
- Surgical complication [within 1st week following surgery]
Rate of new deficits following surgery (excluding new endocrine deficits)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
complex craniopharyngioma > 1cm extension within 2 or more cranial fossae or ventricular system
-
Patient or legal representative able to provide written informed consent
Exclusion Criteria:
-
tumor size< 1 cm
-
Patients with any condition considered a contraindication to MRI
-
Patients with any condition considered a contraindication for surgery
-
Hypothalamic disturbances
-
Hypothalamic edema
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Neurosurgery University of Erlangen | Erlangen | Germany | 91052 |
Sponsors and Collaborators
- Hofmann, Bernd, M.D.
Investigators
- Principal Investigator: Bernd Hofmann, MD,
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Cranio 15